Detalhe da pesquisa
1.
A randomized phase II study of metronomic cyclophosphamide and methotrexate (CM) with or without bevacizumab in patients with advanced breast cancer.
Breast Cancer Res Treat
; 204(1): 123-132, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38019444